I'll make the call on it now: LABS and VerdeMed are in M&Atalks because Pidduck drops the small bomb of generic Epidiolex but yet releases no partner names, etc. Instead we read about the activity in news articles. LABS is the only in North America holding a Canadian DEL and U.S. FDA approvals for cannabinoid API's. Nuff said!
Verdemed has a talented team of experts working in Clinical Trials, Medical Affairs, Pharmaceutical Formulations Development, and Regulatory Affairs. The company consults with a select group of experienced leaders in the pharmaceutical industry across Latin America, and has exclusive access to product suppliers in Canada, along with regulatory advisors and medical consultants across the region.